Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors (Q37446311)
Jump to navigation
Jump to search
scientific article published on 03 January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors |
scientific article published on 03 January 2014 |
Statements
1 reference
Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors (English)
1 reference
L Rhoda Molife
1 reference
Li Yan
1 reference
Joanna Vitfell-Rasmussen
1 reference
Adriane M Zernhelt
1 reference
Daniel M Sullivan
1 reference
Philippe A Cassier
1 reference
Eric Chen
1 reference
Andrea Biondo
1 reference
Ernestina Tetteh
1 reference
Lillian L Siu
1 reference
Amita Patnaik
1 reference
Kyriakos P Papadopoulos
1 reference
Johann S de Bono
1 reference
Anthony W Tolcher
1 reference
Susan Minton
1 reference
3 January 2014
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference